CEA and CA-19.9 Serum Tumor Markers as Prognostic Factors in Patients with Locally Advanced (Unresectable) or Metastatic Pancreatic Adenocarcinoma: A Retrospective Analysis

REFERENCES

• Takai S, Satoi S, Toyokawa H, Yangimoto H, Sugimoto N, Tsuji K, et al. Clinicopathologic evaluation after resection for duc-tal adenocarcinoma of the pancreas: a retrospective, single-insti-tution experience. Pancreas 2003; 26: 243–249.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Kondo S, Sugiura H, Katoh H. Preoperative predictors of short-term survival after pancreatic cancer resec-tion. Hepato-Gasterenterology 1998; 45: 2399–2403.
   PubMed Web of Science ®Google Scholar
• Cady B, Jenkins RL, Steele GD, Lewis D, Stone MD, Mc-Dermott WV, et al. Surgical margin in hepatic resection for col-orectal metastasis. A critical and improvable determinant of outcome. Ann Surg 1998; 227: 566–571.
   Google Scholar
• Micke O, Bruns F, Schafer U, Kurowski R, Horst E, Willich N. CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with ra-diochemotherapy. Anticancer Res. 2003; 23: 835–840.
   PubMed Web of Science ®Google Scholar
• Ziske C, Schlie C, Gorschluter M, Glasmacher A, Mey U, Strehl J, et al. Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemc-itabine. Br J Cancer 2003; 89: 1413-1417.
   Google Scholar
• Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004; 363: 1049–1057.
   PubMed Web of Science ®Google Scholar
• Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base Report on pancreatic cancer. Cancer 1995; 76: 1671–1677.
   PubMed Web of Science ®Google Scholar
• Reber HA, Gloor B. Radical pancreatectomy. Surg Oncol Clin North Am 1998; 7: 157–163.
   PubMedGoogle Scholar
• Fong Y, Blumgart LH, Fortner JG, Brennan MF. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 1995; 222: 426–437.
   PubMed Web of Science ®Google Scholar
• Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, et al. Pancreaticoduodenectomy for pancreatic ade-nocarcinoma: prospective adjuvant chemoradiation improves sur-vival: a prospective, single institution experience. Ann Surg 1997; 225: 621–636.
   PubMed Web of Science ®Google Scholar
• Conlon KC, Klimstra DS, Brennan MF. Long-term sur-vival after curative resection for pancreatic ductal adenocarci-noma. Clinicopathologic analysis of 5-year survivors. Ann Surg. 1996; 223: 273–279.
   Google Scholar
• Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 1996; 83: 625–631.
   PubMed Web of Science ®Google Scholar
• Magistrelli P, Antinori A, Crucitti A, Le Greca A, Masetti R, Coppola R, et al. Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol 2000; 74: 36–40.
   PubMed Web of Science ®Google Scholar
• Matsuno S, Egawa S, Shibuya K, Shimamura H, Suna-mura M, Takeda K, et al. Pancreatic cancer: current status of treatment and survival of 16071 patients diagnosed from 1981-1996, using the Japanese National Pancreatic Cancer Database. Int J Clin Oncol 2000; 5: 153–157.
   Google Scholar
• Link KH, Gansauge F, Goerich J, Leder G, Rillinger N, Berger HG. Palliative and adjuvant regional chemotherapy in pancreatic cancer. Eur J Surg Oncol 1997; 23: 409–414.
   PubMed Web of Science ®Google Scholar
• Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boit-nott JK, Seidler AJ, et al. Factors influencing survival after pan-creaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161: 120–125.
   PubMed Web of Science ®Google Scholar
• Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, et al. Preoperative and postoperative chemoradia-tion strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997; 15: 928–937.
   PubMed Web of Science ®Google Scholar
• Miller AR, Robinson EK, Lee JE, Pisters PW, Chiao PJ, Lenzi RL, et al. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Surg Oncol Clin North Am 1998; 7: 183–197.
   PubMedGoogle Scholar
• Cubiella J, Castells A, Fondevila C, Sans M, Sabater L, Navarro S, et al. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials. Am J Gastroenterol 1999; 94: 1271–1278.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Okada S, Tokuuye K, Ueno H, Okusaka T. Prog-nostic factors in patients with locally advanced pancreatic carci-noma receiving chemoradiotherapy. Cancer 2001; 91: 490–495.
   PubMed Web of Science ®Google Scholar
• Ueno H, Okada S, Okusaka T, Ikeda M. Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 2000; 59: 296–301.
   PubMed Web of Science ®Google Scholar
• Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gas-trointest Surg 2000; 4: 567–579.
   PubMed Web of Science ®Google Scholar
• Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-five consecutive pan-creaticoduodenectomies without mortality. Ann Surg 1993; 217: 430–438.
   PubMed Web of Science ®Google Scholar
• Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995; 221: 721–733.
   PubMed Web of Science ®Google Scholar
• Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993; 165: 68–73.
   PubMed Web of Science ®Google Scholar
• Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995; 221: 59–66.
   PubMed Web of Science ®Google Scholar
• Kloppel G, Solcia E, Longnecker DS, Capella C, Sobin LH. Histological typing of tumours of the exocrine pancreas (2nd edn.) WHO International Histological Classification of Tumours. Springer-Verlag: Berlin, 1996.
   Google Scholar
• Sobin LH, Wittekind Ch, Eds. UICC TNM classification of malignant tumors. Fifth edition, John Wiley & Sons, Inc., New York, 1997.
   Google Scholar
• Talar-Wojnarowska R, Gasiorowska A, Strzelczyk J, Ja-niak A, Malecka-Panas E. Prognostic factors in the operative and palliative treatment of pancreatic cancer. Neoplasma 2003; 50: 383–387.
   PubMed Web of Science ®Google Scholar
• Safi F, Schlosser W, Falkenreck S, Seger HG. CA19-9 serum course and prognosis of pancreatic cancer. Int J Pancreatology 1996; 20: 155–161.
   PubMedGoogle Scholar
• Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors in-fluencing the short-term results. Ann Surg 1993; 217: 356–368.
   Google Scholar
• Okusaka T, Shuichi O, Hideki U, Ikeda M, Shimada K, Yamamoto J, et al. Abdominal pain in patients with respectable pancreatic cancer with reference to clinopathologic findings. Pan-creas 2001; 22: 279–284.
   Google Scholar